Hepatitis B Safety Screening - ICD-10-CM Quality Payment Program Measure
Quality Measure | Description | High Priority | Submission Methods |
---|---|---|---|
Hepatitis B Safety Screening | If a patient is newly initiating biologic OR new synthetic DMARD therapy (e.g. methotrexate, leflunomide, etc.), then the medical record should indicate appropriate screening for hepatitis B in the preceding 12 month period. | YES | Registry |
Linked ICD-10 Codes
The following ICD-10-CM codes are linked to the quality measure hepatitis b safety screening when used as part of a patient's medical record. This Quality Measure is part of Medicare's Quality Payment Program (QPP).
ICD Code | Description | Category |
---|